Hypertension as a hemodynamic disease: the role of impedance cardiography in diagnostic, prognostic, and therapeutic decision making.

Hypertension is the most common cardiovascular disease, affecting approximately 60 million Americans. Despite the importance of this condition, only the minority of patients are appropriately identified and treated to reach recommended blood pressure (BP) goals. Although historically defined as an elevation of BP alone, hypertension is characterized by abnormalities of cardiac output, systemic vascular resistance, and arterial compliance. These hemodynamic aspects of hypertension have implications for diagnosis, risk stratification, and treatment. Impedance cardiography (ICG) has emerged as a unique and highly accurate noninvasive tool that is used to assess hemodynamic parameters. Measurement of the various hemodynamic components using ICG in those with hypertension allows more complete characterization of the condition, a greater ability to identify those at highest risk, and allows more effectively targeted drug management. This article reviews the importance of hemodynamic factors in hypertension and the evolving role of ICG technology in the assessment and management of this important cardiovascular condition.

[1]  E. Frohlich.  Local hemodynamic changes in hypertension: insights for therapeutic preservation of target organs. , 2001, Hypertension.

[2]  A. Sherwood,et al.  Changes in hemodynamics and left ventricular structure after menopause. , 2002, The American journal of cardiology.

[3]  P. Lund-johansen.  Hemodynamic patterns in the natural history of borderline hypertension. , 1986, Journal of cardiovascular pharmacology.

[4]  A. Labovitz,et al.  Effect of treatment of isolated systolic hypertension on left ventricular mass. , 1998, JAMA.

[5]  L. Resnick,et al.  Differential effects of antihypertensive drug therapy on arterial compliance. , 2000, American journal of hypertension.

[6]  N. Albert,et al.  Equivalence of the bioimpedance and thermodilution methods in measuring cardiac output in hospitalized patients with advanced, decompensated chronic heart failure. , 2004, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[7]  J. Mehlsen,et al.  Electrical impedance measured changes in thoracic fluid content during thoracentesis. , 1994, Clinical physiology.

[8]  J. Panza,et al.  High-normal blood pressure--more "high" than "normal". , 2001, The New England journal of medicine.

[9]  W. Shoemaker,et al.  Non-invasive determination of cardiac output by Doppler echocardiography and electrical bioimpedance , 1990, British heart journal.

[10]  S. Franklin.  Blood pressure and cardiovascular disease: what remains to be achieved? , 2001, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[11]  R. Ross.  Atherosclerosis is an inflammatory disease , 1999 .

[12]  S. Oparil,et al.  Normotensive blacks have heightened sympathetic response to cold pressor test. , 1993, Hypertension.

[13]  T. Nishikimi,et al.  Left ventricular systolic and diastolic function and mass before and after antihypertensive treatment in patients with essential hypertension. , 1997, Hypertension research : official journal of the Japanese Society of Hypertension.

[14]  J. Alfie,et al.  Contribution of stroke volume to the change in pulse pressure pattern with age. , 1999, Hypertension.

[15]  M. Drazner,et al.  Comparison of impedance cardiography with invasive hemodynamic measurements in patients with heart failure secondary to ischemic or nonischemic cardiomyopathy. , 2002, The American journal of cardiology.

[16]  J. Izzo,et al.  Arterial stiffness and the systolic hypertension syndrome , 2004, Current opinion in cardiology.

[17]  N. Westerhof,et al.  Reliability of stroke volume to pulse pressure ratio for estimating and detecting changes in arterial compliance. , 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[18]  J. Levy,et al.  Relationship between clinical evaluation of peripheral perfusion and global hemodynamics in adults after cardiac surgery , 1990, Critical care medicine.

[19]  T. Kahan.  The importance of left ventricular hypertrophy in human hypertension. , 1998, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[20]  Donald L Sharman,et al.  Improvement in blood pressure control with impedance cardiography-guided pharmacologic decision making. , 2004, Congestive heart failure.

[21]  L. Cámera,et al.  Diastolic pressure underestimates age-related hemodynamic impairment. , 1997, Hypertension.

[22]  R. S. Eliot.  The dynamics of hypertension--an overview: present practices, new possibilities, and new approaches. , 1988, American heart journal.

[23]  J. Sullivan,et al.  Short-term therapy of severe hypertension. Hemodynamic correlates of the antihypertensive response in man. , 1979, Archives of internal medicine.

[24]  T. Whitsett,et al.  Cardiovascular effects of caffeine in men and women. , 2004, The American journal of cardiology.

[25]  Ernesto L. Schiffrin,et al.  Vascular Remodeling in Hypertension: Roles of Apoptosis, Inflammation, and Fibrosis , 2001, Hypertension.

[26]  R. Lewanczuk,et al.  Vascular compliance is reduced in the early stages of type 1 diabetes. , 2001, Diabetes care.

[27]  H. Tsukiyama.  Choice of antihypertensive agents in hemodynamic aspects to match pathophysiology and pharmacology in essential hypertension. , 1989, Japanese journal of medicine.

[28]  G. Reboldi,et al.  Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy. , 1996, The American journal of cardiology.

[29]  M. Motolese,et al.  Left ventricular hypertrophy regression in hypertensive patients treated with metoprolol. , 1984, International journal of clinical pharmacology, therapy, and toxicology.

[30]  G. Mensah,et al.  Stroke volume/pulse pressure ratio and cardiovascular risk in arterial hypertension. , 1999, Hypertension.

[31]  H. Black,et al.  Resistant hypertension in a tertiary care clinic. , 1991, Archives of internal medicine.

[32]  D. Teres,et al.  Therapeutic impact of pulmonary artery catheterization in a medical/surgical ICU. , 1991, Chest.

[33]  J. J. Smith,et al.  The use of thoracic impedance for determining thoracic blood volume changes in man. , 1986, Aviation, space, and environmental medicine.

[34]  N. Schork,et al.  Hyperkinetic borderline hypertension in Tecumseh, Michigan , 1991, Journal of hypertension.

[35]  G. Lehmann,et al.  Blood pressure and aortic elastic properties--verapamil SR/trandolapril compared to a metoprolol/hydrochlorothiazide combination therapy. , 1998, International journal of clinical pharmacology and therapeutics.

[36]  P. Lund-johansen.  Newer thinking on the hemodynamics of hypertension , 1994, Current opinion in cardiology.

[37]  S. Textor,et al.  A hemodynamic approach to resistant hypertension. , 2000, Congestive heart failure.

[38]  B. Sramek.  Normohemodynamic goal-oriented antihypertensive therapy improves the outcome. , 1996 .

[39]  R. Schmieder,et al.  Disparate cardiovascular findings in men and women with essential hypertension. , 1987, Annals of internal medicine.

[40]  J. J. Ríos Blanco,et al.  Noninvasive Study of Endothelial Function in White Coat Hypertension , 2002, Hypertension.

[41]  E. Frohlich,et al.  Hypertension and the heart , 2000, Current hypertension reports.

[42]  J. Cohn,et al.  Prognostic application of arterial stiffness: task forces. , 2002, American journal of hypertension.

[43]  F. Messerli,et al.  Essential hypertension in black and white subjects. Hemodynamic findings and fluid volume state. , 1979, The American journal of medicine.

[44]  T. Benedetti,et al.  Antihypertensive Therapy in Pregnancy Directed by Noninvasive Hemodynamic Monitoring , 1989, American journal of perinatology.

[45]  V. Pavlik,et al.  Characteristics of patients with uncontrolled hypertension in the United States. , 2001, The New England journal of medicine.

[46]  E. Freis.  Hemodynamics of hypertension. , 1960, Physiological reviews.

[47]  B. Spiess,et al.  Equivalence of bioimpedance and thermodilution in measuring cardiac index after cardiac surgery. , 2002, Journal of cardiothoracic and vascular anesthesia.

[48]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[49]  S. Julius,et al.  Autonomic nervous system dysregulation in human hypertension. , 1991, The American journal of cardiology.

[50]  M. Peach,et al.  Factors That Contribute to Resistant Forms of Hypertension: Pharmacological Considerations , 1988, Hypertension.

[51]  J. Dimsdale,et al.  Mood states and impedance cardiography-derived hemodynamics , 2001, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[52]  Ron Z. Goetzel,et al.  Health, Absence, Disability, and Presenteeism Cost Estimates of Certain Physical and Mental Health Conditions Affecting U.S. Employers , 2004, Journal of occupational and environmental medicine.

[53]  David A Calhoun,et al.  Pathogenesis of Hypertension , 2003, Annals of Internal Medicine.

[54]  W. Judy,et al.  Comparison of the effects of pindolol and atenolol on hemodynamic function in systemic hypertension. , 1988, The American journal of cardiology.

[55]  Pascal Verdonck,et al.  Pulmonary arterial compliance in dogs and pigs: the three-element windkessel model revisited. , 1999, American journal of physiology. Heart and circulatory physiology.

[56]  W. Kubicek,et al.  An impedance cardiographic study of the mechanism of blood pressure fall after moderate dietary sodium restriction. , 1985, Japanese heart journal.

[57]  J. Molnar,et al.  Relation of left ventricular mass and QT dispersion in patients with systematic hypertension. , 1997, The American journal of cardiology.

[58]  S. Taylor,et al.  Hemodynamic differences between metoprolol and carvedilol in hypertensive patients. , 1998, American journal of hypertension.

[59]  S. Glasser.  Hypertension syndrome and cardiovascular events , 2001, Postgraduate medicine.

[60]  R. Gifford.  Resistant Hypertension Introduction and Definitions , 1988, Hypertension.

[61]  R. Collins,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.

[62]  B. Davis,et al.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2002, JAMA.

[63]  Yves Lecarpentier,et al.  Total arterial compliance estimated by stroke volume-to-aortic pulse pressure ratio in humans. , 1998, American journal of physiology. Heart and circulatory physiology.

[64]  Y. Kawano,et al.  Effects of salt, prostaglandin, and captopril on vascular responsiveness in essential hypertension. , 1989, American journal of hypertension.

[65]  H. Black,et al.  Refractory hypertension. , 1992, The New England journal of medicine.

[66]  A. Maggioni,et al.  Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study. , 2001, Journal of the American College of Cardiology.

[67]  Charles W Parrott,et al.  Comparison of changes in ejection fraction to changes in impedance cardiography cardiac index and systolic time ratio. , 2004, Congestive heart failure.

[68]  W. Elliott,et al.  The Economic Impact of Hypertension , 2003, Journal of clinical hypertension.

[69]  S. Textor,et al.  Resistant Hypertension: Comparing Hemodynamic Management to Specialist Care , 2002, Hypertension.

[70]  C. Wiggers.  The dynamics of hypertension , 1938 .

[71]  C. A. Cadwell,et al.  Reproducibility of noninvasive bioimpedance measurements of cardiac function , 1998 .

[72]  F. Dunn,et al.  Impaired systemic arterial compliance in borderline hypertension. , 1984, American heart journal.

[73]  P. Okin,et al.  Prognostic implications of left ventricular hypertrophy. , 2001, American heart journal.

[74]  S. Yusuf,et al.  Reduction of Cardiovascular Risk by Regression of Electrocardiographic Markers of Left Ventricular Hypertrophy by the Angiotensin-Converting Enzyme Inhibitor Ramipril , 2001, Circulation.

[75]  N. Albert,et al.  Equivalence of bioimpedance and thermodilution in measuring cardiac output and index in patients with advanced, decompensated chronic heart failure hospitalized in critical care , 2003 .

[76]  E. Freis.  Studies in hemodynamics and hypertension. , 2001, Hypertension.

[77]  R. Devereux,et al.  Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis. , 2003, American journal of hypertension.

[78]  A C Guyton,et al.  The relationship of cardiac output and arterial pressure control. , 1981, Circulation.

[79]  J. Laragh,et al.  Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. , 1992, Journal of the American College of Cardiology.

[80]  Richard N Channick,et al.  Comparison of impedance cardiography to direct Fick and thermodilution cardiac output determination in pulmonary arterial hypertension. , 2004, Congestive heart failure.

[81]  H. Black,et al.  Current concepts refractory hypertension , 1992 .

[82]  A. Sherwood,et al.  Ethnic differences in left ventricular structure: relations to hemodynamics and diurnal blood pressure variation. , 2004, American journal of hypertension.

[83]  M. Galderisi,et al.  Effort blood pressure control in the course of antihypertensive treatment. , 1989, The American journal of medicine.

[84]  J. Aldrete,et al.  Pacemaker malfunction due to microcurrent injection from a bioimpedance noninvasive cardiac output monitor , 1995, Journal of clinical monitoring.

[85]  J. Staessen,et al.  The pulse pressure-to-stroke index ratio predicts cardiovascular events and death in uncomplicated hypertension. , 2001, Journal of the American College of Cardiology.

[86]  J. Schwartz,et al.  Relation of Age to Left Ventricular Function and Systemic Hemodynamics in Uncomplicated Mild Hypertension , 2001, Hypertension.

[87]  N. Dawson,et al.  Hemodynamic status in critically ill patients with and without acute heart disease. , 1990, Chest.

[88]  B. Egan,et al.  The importance of hemodynamic considerations in essential hypertension. , 1988, American heart journal.

[89]  H. Koomans,et al.  Effects of Endothelin‐1 and Endothelin‐1 Receptor Blockade on Cardiac Output, Aortic Pressure, and Pulse Wave Velocity in Humans , 2003, Hypertension.

[90]  S. Tibby,et al.  Clinicians’ abilities to estimate cardiac index in ventilated children and infants , 1997, Archives of disease in childhood.

[91]  Schappert Sm,et al.  National Ambulatory Medical Care Survey: 1995-96 summary. , 1999, Vital and health statistics. Series 13, Data from the National Health Survey.

[92]  R. Vogel,et al.  Impedance cardiography: the next vital sign technology? , 2003, Chest.

[93]  J. Staessen,et al.  Prognostic value of invasive hemodynamic measurements at rest and during exercise in hypertensive men. , 1996, Hypertension.

[94]  Theodore C. Janeway,et al.  A CLINICAL STUDY OF HYPERTENSIVE CARDIOVASCULAR DISEASE , 1913 .

[95]  R B D'Agostino,et al.  Determinants of isolated systolic hypertension. , 1988, JAMA.

[96]  S. Oparil,et al.  Managing the patient with hard-to-control hypertension. , 1998, American family physician.

[97]  S. Yusuf,et al.  Effects of Ramipril on Coronary Events in High-Risk Persons: Results of the Heart Outcomes Prevention Evaluation Study , 2001, Circulation.